Skip to content

Genetic testing review reports improved antidepressant response at early follow-ups

For people with depression, a review reports improved treatment response and remission with genetic testing before antidepressant treatment. The abstract leaves the size of these advantages unclear.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

For people with depression, the review reports improved antidepressant response rates with genetic testing at early follow-ups. It separately reports improved remission and suggests remission occurred sooner than with usual care. Reported advantages were less pronounced in available longer-term observations. Without effect estimates or confidence intervals, their size and precision remain unclear.

Keep in mind

This abstract-based summary cannot assess individual study results or study quality. The abstract supplies no participant totals or numerical effect estimates, limiting assessment of the consistency and size of the reported advantages.

THE RESULT, WITH CONTEXT

What researchers found

Improved response rates were reported

Antidepressant treatment response

Compared with usual care at 8 and 12 weeks. The abstract supplies no numerical effect estimate or confidence interval for this endpoint.

Pharmacogenomics, 2025 · Original source ↓

What testing examined

The review examined genetic testing related to how the body processes antidepressants. Its question was whether testing before treatment improved clinical response and remission, rather than whether testing could simply identify differences in drug metabolism.

Response and remission differ

Improved response rates at scheduled assessments do not establish faster attainment of response. The abstract makes its timing claim specifically about remission. Available later observations suggested a smaller advantage, leaving the durability of the reported improvements unclear.

CHECK THE ORIGINAL

The original publication

Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review.

Tavakoli E, Magarbeh L, Elsheikh S et al.
Pharmacogenomics · 2025

PubMed ID
40754894
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.